China Universal Asset Management Company’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $399K | Buy |
22,391
+344
| +2% | +$6.12K | 0.04% | 259 |
|
|
2025
Q1 | $393K | Sell |
22,047
-896
| -4% | -$16K | 0.04% | 265 |
|
|
2024
Q4 | $684K | Buy |
22,943
+2,129
| +10% | +$63.4K | 0.06% | 211 |
|
|
2024
Q3 | $325K | Buy |
20,814
+8,172
| +65% | +$128K | 0.04% | 261 |
|
|
2024
Q2 | $217K | Sell |
12,642
-7,938
| -39% | -$136K | 0.03% | 228 |
|
|
2024
Q1 | $322K | Buy |
20,580
+8,217
| +66% | +$128K | 0.04% | 233 |
|
|
2023
Q4 | $185K | Buy |
12,363
+9,624
| +351% | +$144K | 0.04% | 211 |
|
|
2023
Q3 | $44.2K | Buy |
2,739
+1,347
| +97% | +$21.8K | 0.01% | 235 |
|
|
2023
Q2 | $57.8K | Sell |
1,392
-37
| -3% | -$1.54K | 0.02% | 182 |
|
|
2023
Q1 | $85.9K | Buy |
1,429
+363
| +34% | +$21.8K | 0.03% | 130 |
|
|
2022
Q4 | $78.2K | Buy |
1,066
+85
| +9% | +$6.24K | 0.03% | 126 |
|
|
2022
Q3 | $75K | Buy |
+981
| New | +$75K | 0.03% | 116 |
|